This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Peter Marks, the head of the FDA's Center for Biologics Evaluation and Research ...
Novartis’ prostate cancer radiopharmaceutical Pluvicto has netted a highly antic...
Medicaid and SNAP cuts could lead to 1 million jobs lost in just 2026, according...
What You Should Know: – The U.S. Department of Health and Human Services (HHS) ...
What You Should Know: – GE HealthCare launches of its Revolution Vibe CTi, a ne...
The terms align with the company's brain-computer interface technologies aimed a...
About 90% of healthcare organizations are insecurely connected to the internet a...
CZ Biohub San Francisco and CZ Institute for Advanced Biological Imaging join fo...
On Tuesday, drug discoverer and biotech entrepreneur Alpha Lee told scientists a...
Lykos Therapeutics’ interim CEO Michael Mullette is planning to step down, accor...
A rival group is seeking to buy cell therapy biotech bluebird bio, in an effort ...
A federal judge on Friday dismissed Amgen’s lawsuit against Colorado's drug affo...
The FDA on Friday said it approved a new RNAi-based hemophilia treatment from Sa...
Novartis’ prostate cancer radiopharmaceutical Pluvicto has netted a highly antic...
Validic partners with Person Family Medical Center to promote heart health and H...
The report said the technology has helped reduce clinician burnout while improvi...